Metformin: A New Inhibitor of the Wnt Signaling Pathway in Cancer

The biguanide drug metformin is widely used in type 2 diabetes mellitus therapy, due to its ability to decrease serum glucose levels, mainly by reducing hepatic gluconeogenesis and glycogenolysis. A considerable number of studies have shown that metformin, besides its antidiabetic action, can improv...

Descripción completa

Detalles Bibliográficos
Autores principales: Conza, Domenico, Mirra, Paola, Fiory, Francesca, Insabato, Luigi, Nicolò, Antonella, Beguinot, Francesco, Ulianich, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486775/
https://www.ncbi.nlm.nih.gov/pubmed/37681914
http://dx.doi.org/10.3390/cells12172182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486775/
https://www.ncbi.nlm.nih.gov/pubmed/37681914
http://dx.doi.org/10.3390/cells12172182

Ejemplares similares